The Evolution of Antimicrobial Resistance in Respiratory Pathogens in Canada: What are the Clinical Consequences? by Donald E Low

Get full text

A Prospective Open-Label Multicentre Trial on the Use of 1 G, Once Daily Ceftriaxone in Lower Respiratory Tract Infections by Donald E Low, Lionel A Mandell

Get full text

Launching of the CAN-R Web Site –The Official Web Site of the Canadian Antimicrobial Resistance Alliance by George G Zhanel, Donald E Low

Get full text

The Threat of the Emergence of Antimicrobial-Resistant Gram-Positive Pathogens in Canada by Donald E Low, Barbara M Willey, Allison J McGeer

Get full text

Comparative Activity of Several Antimicrobial Agents against Nosocomial Gram-Negative Rods Isolated across Canada by Shelley R Scriver, Canadian Antimicrobial Resistance Study Group, Donald E Low

Get full text

In Vitro Activity of Cefepime against Multidrug-Resistant Gram-Negative Bacilli, Viridans Group Streptococci and Streptococcus pneumoniae from a Cross-Canada Surveillance Study by Donald E Low, Joyce de Azavedo, Canadian Bacterial Surveillance Network, Ross Davidson

Get full text

Community-Acquired Antibiotic Resistance in Urinary Isolates from Adult Women in Canada by Warren J McIsaac, Tony Mazzulli, Joanne Permaul, Rahim Moineddin, Donald E Low

Get full text

A Comparison of Bacteremic Pneumococcal Pneumonia with Nonbacteremic Community-Acquired Pneumonia of Any Etiology — Results from a Canadian Multicenter Study by Thomas J Marrie, Donald E Low, Emidio de Carolis, the Canadian Community-Acquired Pneumonia Investigators

Get full text

Canadian Guidelines for the Management of Acute Exacerbations of Chronic Bronchitis by Meyer S Balter, Jacques La Forge, Donald E Low, Lionel Mandell, Ronald F Grossman, the Chronic Bronchitis Working Group

Get full text

Cross-Canada Survey of Resistance of 2747 Aerobic Blood Culture Isolates to Piperacillin/Tazobactam and Other Antibiotics by Kevin R Forward, Patricia A Franks, Donald E Low, Robert Rennie, Andrew E Simor, the Canadian Piperacillin/Tazobactam Study Group

Get full text

Community-Acquired Pneumonia in Children: A Multidisciplinary Consensus Review by Donald E Low, James D Kellner, Upton Allen, Francois D Boucher, Thomas Kovesi, John Riesman, Ross Davidson, Joanne M Langley

Get full text

Cotrimoxazole-Resistant Escherichia coli Bacteremia in Neutropenic Patients at a Regional Oncology Hospital by Daniel B Gregson, Anne G Matlow, Andrew E Simor, Peter G Tuffnell, Donald E Low, Ronald Feld, James E Brunton

Get full text

Comparative Antifungal Activity of Cilofungin (LY121019) against Candida Species, Including Evaluation of Susceptibility Testing Method by Abdul H Chagla, John H Hii, Daryl J Hoban, Andrew E Simor, Santiago Ferro, Evelyn Witwicki, Ruby Poon, Donald E Low

Get full text

Study of the Comparative Activity of Piperacillin/Tazobactam with Currently Available Antibiotics against 8206 Aerobic Isolates by Kevin R Forward, Donald E Low, Michel Laverdiere, Robert Rennie, Andrew E Simor, Patricia A Franks, Members of the Canadian Piperacillin/Tazobactam Study Group

Get full text

Classification, Diagnosis and Treatment of Sinusitis: Evidence-Based Clinical Practice Guidelines by Arnold Noyek, David Brodovsky, Stephen Coyle, Martin Desrosiers, Saul Frenkiel, Michael Hawke, James D Kellner, David A Kirkpatrick, Sigmund Krajden, Donald E Low, Lionel Mandell, Bernard Marlow, Gerald F Martin, Richard Rival, Lalitha Shankar, David Vaughan, Ian J Witterick

Get full text